Abstract
Triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan is a standard therapy for metastatic colorectal cancer (CRC). Single nucleotide polymorphisms (SNPs) in DPYD and UGT1A1 influence fluoropyrimdines and irinotecan adverse events (AEs). Low frequency DPYD variants (c.1905 + 1G > A, c.1679 T > G, c.2846A > T) are validated but more frequent ones (c.496A > G, c.1129-5923C > G and c.1896 T > C) are not. rs895819 T > C polymorphism in hsa-mir-27a is associated with reduced DPD activity. In this study, we evaluated the clinical usefulness of a pharmacogenetic panel for patients receiving triplet combinations. Germline DNA was available from 64 CRC patients enrolled between 2008 and 2013 in two phase II trials of capecitabine, oxaliplatin and irinotecan plus bevacizumab or cetuximab. SNPs were determined by Real-Time PCR. We evaluated the functional variants in DPYD (rare: c.1905 + 1G > A, c.1679 T > G, c.2846A > T; most common: c.496A > G, c.1129-5923C > G, c.1896 T > C), hsa-mir-27a (rs895819) and UGT1A1 (*28) genes to assess their association with grade 3-4 AEs. None of the patients carried rare DPYD variants. We found DPYD c.496A > G, c.1129-5923C > G, c.1896 T > C in heterozygosity in 19%, 5% and 8%, respectiv...Continue Reading
References
Nov 25, 2003·Human Mutation·Eva GrossMarion Kiechle
Dec 6, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christophe TournigandAimery de Gramont
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GrotheyHans-Joachim Schmoll
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alfredo FalconeUNKNOWN Gruppo Oncologico Nord Ovest
Sep 8, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaS Pusceddu
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles S FuchsJosé Barrueco
Dec 11, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C-H KöhneE Van Cutsem
Dec 24, 2008·PloS One·Eva GrossAlfons Meindl
Jan 8, 2009·American Journal of Epidemiology·Santiago RodriguezIan N M Day
Jun 18, 2009·Pharmacogenomics·Ursula AmstutzCarlo R Largiadèr
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemUNKNOWN ESMO Guidelines Working Group
Jul 10, 2010·Anti-cancer Drugs·Linda J M OostendorpPetronella B Ottevanger
Aug 31, 2010·Human Genetics·André B P van KuilenburgEva Gross
Jul 7, 2011·Chest·David L Streiner, Geoffrey R Norman
Feb 7, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takeshi HirotaIchiro Ieiri
Jun 6, 2013·British Journal of Cancer·A LoganayagamA M Marinaki
Aug 15, 2013·Therapeutic Drug Monitoring·Lay Kek TehMohd Zaki Salleh
Aug 31, 2013·Clinical Pharmacology and Therapeutics·K E CaudleM Schwab
Oct 22, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LoupakisA Falcone
Jan 10, 2014·Molecular Cancer Therapeutics·Steven M OfferRobert B Diasio
Feb 5, 2014·Pharmacogenetics and Genomics·Julia M BarbarinoRuss B Altman
Jun 25, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico InnocentiMark J Ratain
Jun 26, 2014·British Journal of Clinical Pharmacology·Roberto IacovelliMaria Di Bartolomeo
Oct 23, 2014·The New England Journal of Medicine·Fotios LoupakisAlfredo Falcone
Dec 30, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T GruenbergerR Adam
Feb 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria Di BartolomeoEmilio Bajetta
May 1, 2014·Personalized Medicine·Felicia Stefania FalvellaFilippo Pietrantonio
Citations
Apr 24, 2015·International Journal of Molecular Sciences·Felicia Stefania FalvellaFilippo Pietrantonio
Dec 31, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carin A T C LunenburgHans Gelderblom
Aug 5, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Paolo PellegrinoSonia Radice
Jun 18, 2015·Frontiers in Pharmacology·Stefania CheliFelicia S Falvella
Jul 10, 2016·Clinical Pharmacokinetics·Francis LéviEtienne Chatelut
Sep 13, 2016·International Journal of Molecular Sciences·Vid MlakarMarc Ansari
Oct 4, 2016·Drug Discovery Today·Harshali PatilRupinder K Kanwar
Jan 12, 2017·Clinical Pharmacology and Therapeutics·R RoncatoG Toffoli
Mar 16, 2017·Clinical Pharmacology and Therapeutics·Q NieR B Diasio
Jun 15, 2017·Chemotherapy·Felicia Stefania FalvellaMassimiliano Cergnul
Sep 13, 2018·Drug Metabolism and Personalized Therapy·Mohammed ZawiahAbdel Rahman Ajaj
Aug 18, 2017·British Journal of Cancer·Francis LéviAntoinette Lemoine
Jun 24, 2017·BMC Cancer·Dan LiuLin Shen
Sep 13, 2019·Expert Opinion on Drug Metabolism & Toxicology·Giuseppe MiscioDavide Seripa
Nov 2, 2017·Oncotarget·Muxiong ChenYu Weng
Aug 31, 2018·Oncotarget·Gemma BrueraUNKNOWN Oncology Network ASL1 Abruzzo, Italy
Apr 27, 2017·International Journal of Colorectal Disease·R AarnoutseM L Smidt
Feb 21, 2019·The New England Journal of Medicine·Aditya BardiaKevin Kalinsky
Jun 18, 2019·Therapeutic Advances in Medical Oncology·Gemma BrueraEnrico Ricevuto
Mar 11, 2020·Frontiers in Oncology·Gemma Bruera, Enrico Ricevuto
Aug 28, 2020·Frontiers in Oncology·Gemma BrueraEnrico Ricevuto
Oct 28, 2017·Frontiers in Pharmacology·Nurul-Syakima Ab MutalibRahman Jamal
Jul 1, 2020·Expert Opinion on Drug Metabolism & Toxicology·Gloria RavegniniSabrina Angelini
Oct 7, 2020·Clinical Pharmacology and Therapeutics·Jonathan E KnikmanLinda M Henricks
Oct 10, 2020·Surgical Oncology·E Puerta-GarcíaM Cañadas-Garre
Nov 25, 2020·Journal of Personalized Medicine·Ana Rita SimõesÁngel Carracedo
Nov 26, 2020·Pharmacogenomics and Personalized Medicine·Gemma BrueraUNKNOWN Oncology Network ASL1 Abruzzo
Mar 19, 2021·Pharmacogenomics·Amirsaeed Sabeti AghabozorgiMohammad Reza Abbaszadegan
Mar 27, 2021·Frontiers in Genetics·Jorge E B da RochaMichèle Ramsay
Jan 26, 2021·British Journal of Clinical Pharmacology·Seid HamzicCarlo R Largiadèr
Aug 28, 2021·Journal of Personalized Medicine·Priscila VillalvazoLuis Andrés López-Fernández
Sep 11, 2021·The Oncologist·Bhavina B SharmaGabriel A Brooks